Artificial intelligence is reshaping how patients and doctors access medicine information, but a new comprehensive review shows that pharmacists are emerging as the essential human check on AI accuracy. Researchers from the University of Bath, University College London, and King's College London analyzed 14 peer-reviewed studies on AI-driven medicines information and found that while AI tools show real promise in supporting pharmacy services, they still struggle with accuracyâespecially when handling complex clinical questions. The critical finding: pharmacists were the most engaged healthcare professionals evaluating AI-generated content, yet their role remains poorly defined. What Can AI Actually Do for Medicine Information? AI is being tested across pharmacy practice to help manage medications, answer drug-related questions, and support clinical decision-making. The technology can analyze vast amounts of medical data and identify patterns that might help pharmacists work more efficiently. However, the research team found that AI tools have significant limitations when it comes to accuracy, particularly when patients or doctors ask complex questions that require nuanced clinical judgment. Out of the 14 studies reviewed, only 3 explored how digital health inequalitiesâlike poor internet access or low digital literacyâaffect whether people can actually use these AI tools. Why Pharmacists Are the Real MVPs in AI Healthcare The scoping review revealed that pharmacists are stepping into a crucial role as validators of AI-generated information. They're the healthcare professionals most actively evaluating whether AI responses are accurate, complete, and safe for patients to use. This makes sense: pharmacists are medication experts who understand drug interactions, side effects, and individual patient needs in ways that AI systemsâtrained on general dataâmay not fully grasp. Yet despite their obvious importance, the research shows that the extent of pharmacist involvement in AI integration and the implications for pharmacy practice remain unclear. Healthcare systems haven't yet created clear guidelines for how pharmacists should work alongside AI tools. The Hidden Barriers Keeping AI Medicine Information From Reaching Everyone One of the most striking findings from the review is that digital health inequalities are a major obstacle to fair AI adoption. The researchers identified three key barriers that prevent equitable access to AI-driven medicines information: - Infrastructure Limitations: Many communities lack reliable internet connectivity or access to the digital devices needed to use AI-powered medicine information tools, creating a two-tier system where some patients benefit while others are left behind. - Digital Literacy Disparities: Even when technology is available, people with lower digital literacy skills may struggle to use AI tools effectively, reducing the potential health benefits for vulnerable populations. - Misinformation Risks and Regulatory Gaps: AI systems can generate plausible-sounding but inaccurate information about medicines, and current regulatory frameworks haven't caught up with the technology, leaving gaps in oversight and safety standards. These barriers matter because they mean that AI's promise to democratize access to medicine information could actually widen existing health disparities if not carefully managed. How to Ensure AI Medicine Information Is Safe and Trustworthy - Establish Clear Pharmacist Oversight Protocols: Healthcare systems should define specific roles and responsibilities for pharmacists in validating AI-generated medicines information, ensuring human expertise remains central to the process. - Develop Accuracy Standards for AI Tools: Create transparent benchmarks for how accurate AI responses must be before they're used in clinical settings, with regular audits to catch errors before they reach patients. - Address Digital Health Inequalities Proactively: Invest in infrastructure and training programs to ensure that underserved communities can access AI-powered medicines information, rather than allowing technology to deepen existing health gaps. - Build Regulatory Frameworks That Keep Pace: Governments and regulatory bodies need to establish clear rules for AI use in medicines information, including requirements for transparency, bias testing, and ongoing monitoring of real-world performance. What Comes Next for AI in Pharmacy? The research team concluded that AI-driven tools show genuine promise in supporting medicines information services, but significant concerns remain. The future depends on three things: first, clearly defining how pharmacists should evaluate and integrate AI tools into their practice; second, identifying and minimizing digital health inequalities so that AI benefits reach all patients fairly; and third, conducting more research on evidence-informed AI implementation in medicines information services. The bottom line is that AI isn't going to replace pharmacistsâit's going to change their job. Instead of spending time answering routine questions, pharmacists will increasingly serve as quality controllers and clinical validators for AI systems. That's actually good news for patients, because it means human expertise remains at the center of medicine information, with AI handling the heavy lifting of data analysis and pattern recognition. But only if we get the implementation right.
